SARS-CoV-2-IN-41 |
| Catalog No.GC71308 |
SARS-CoV-2-IN-41 (composé 2) est un puissant inhibiteur 3clpro du coronavirus de type 2 du syndrome respiratoire aigu sévère avec une IC50 de 0022 µm.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2920904-06-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SARS-CoV-2-IN-41 (compound 2) is a potent SARS-CoV-2 3CLpro inhibitor with an IC50 value of 0.022 µM. SARS-CoV-2-IN-41 shows antiviral effect.
SARS-CoV-2-IN-41 (50, 200 mg/kg; I.p.) antiviral effect in SARS-CoV-2 infected mice[1].
References:
[1]. XiangRui et al. Cyano compound, and preparation method therefor and use thereof. WO2023051657A1.
Review for SARS-CoV-2-IN-41
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for SARS-CoV-2-IN-41
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *